Home › Compare › VIVE vs QYLD

VIVE vs QYLD: Dividend Comparison 2026

VIVE yields 1000000.00% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIVE wins by $4.7683925249533696e+36M in total portfolio value
10 years
VIVE
VIVE
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full VIVE calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — VIVE vs QYLD

📍 VIVE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIVEQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIVE + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VIVE pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIVE
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, VIVE beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIVE + QYLD for your $10,000?

VIVE: 50%QYLD: 50%
100% QYLD50/50100% VIVE
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VIVE right now

VIVE
Analyst Ratings
5
Buy
3
Hold
2
Sell
Consensus: Buy
Altman Z
-35.1
Piotroski
4/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIVE buys
0
QYLD buys
0
No recent congressional trades found for VIVE or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIVEQYLD
Forward yield1000000.00% ✓11.92%
Annual dividend / share$2.00$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.7683925249533696e+36M$25.4K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$5,659.31
Total dividends collected$4.7683311610149396e+36M$27.1K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: VIVE vs QYLD ($10,000, DRIP)

YearVIVE PortfolioVIVE Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,352$1,192.36+$100.00M → VIVE
2$934,786,450,701$934,679,439,252.34$10,830$1,347.57+$934786.44M → VIVE
3$8,165,787,108,578,292$8,164,786,887,076,042.00$11,460$1,539.07+$8165787108.57M → VIVE
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$12,275$1,777.84+$66665884190957.64M → VIVE
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$13,323$2,078.95+$508662171058048128.00M → VIVE
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$14,667$2,463.34+$3.62723524842849e+21M → VIVE
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$16,396$2,960.57+$2.417368115915061e+25M → VIVE
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$18,631$3,612.97+$1.5056740286145463e+29M → VIVE
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$21,548$4,482.15+$8.764771002818475e+32M → VIVE
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$25,398$5,659.31+$4.7683925249533696e+36M → VIVE

VIVE vs QYLD: Complete Analysis 2026

VIVE — Stock

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Full VIVE Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this VIVE vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIVE vs SCHDVIVE vs JEPIVIVE vs OVIVE vs KOVIVE vs MAINVIVE vs XYLDVIVE vs JEPQVIVE vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.